NCT02793323|Completed
Loading search results
Sponsor study identifier
interventional
60
1 country
1
Study Start
June 1, 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 31, 2017
Actual (reported)Study Completion
September 30, 2017
Actual (reported)Shoulder pain is frequently mentioned in recent literature following laparoscopic operations. Several pain relief strategies have been proposed to decrease shoulder tip pain post laparoscopic surgeries. This study will be conducted to compare the Superficial cervical nerve block vs. NSAIDs in terms of shoulder tip pain relief after laparoscopic surgeries.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 30, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 30, 2016
Actual (reported)June 1, 2016
Date type not reportedThis date has not been verified as actual or estimated.
June 8, 2016
Actual (reported)August 31, 2017
Actual (reported)September 30, 2017
Actual (reported)Pain scores assessed through the Visual Analogue Scale (VAS)
48 hours postoperatively
Number of patients receiving analgesics
48 hours postoperatively
Length of hospital stay
An average of 24 hours
Patients will receive superficial cervical nerve block in which we inject 5 ml of local anaesthetic mixture. Each 17 ml of the mixture contain: 6 ml lidocaine 2%, 6 ml lidocaine 2% with adrenaline 5 µg/ml, and 5 ml bupivacaine 0.5. Patients will also receive 100 ml IV saline.
Patients will receive 100 mg (100 ml) IV NSAIDs (Profenid) before induction of anesthesia. Superficial cervical nerve block containing 5 ml placebo will be performed.
A nerve stimulator is used to guide superficial cervical blockade to relieve shoulder pain.
100 mg (100 ml) intravenous NSAIDs (Profenid)
Makassed General Hospital
Beirut, Lebanon
Zoher Naja, MD
Makassed General Hospital
60 participants (actual enrollment reported by the registry).
First Submitted
May 30, 2016
First Posted
June 8, 2016
Study Start
June 1, 2016
Date type not reportedThis date has not been verified as actual or estimated.
General anesthesia is induced with 1 μg/kg fentanyl, 1.5-2 mg/kg propofol and 1-2 mg midazolam. Then, endotracheal intubation is facilitated by 0.15 mg/kg nimbex. Anesthesia is maintained by 1-1.5% sevoflurane, 0.5 μg/kg/h fentanyl, 0.05 mg/kg/h nimbex, 60% nitrous oxide and 40% oxygen
100 ml IV saline
Superficial cervical nerve block containing 5 ml saline
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
August 31, 2017
Actual (reported)Study Completion
September 30, 2017
Actual (reported)Last Updated
November 6, 2017
Record last verified: 2017-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: